DE69122960D1 - Verfahren und zubereitungen für die behandlung von verletzungen - Google Patents

Verfahren und zubereitungen für die behandlung von verletzungen

Info

Publication number
DE69122960D1
DE69122960D1 DE69122960T DE69122960T DE69122960D1 DE 69122960 D1 DE69122960 D1 DE 69122960D1 DE 69122960 T DE69122960 T DE 69122960T DE 69122960 T DE69122960 T DE 69122960T DE 69122960 D1 DE69122960 D1 DE 69122960D1
Authority
DE
Germany
Prior art keywords
injuries
preparations
treatment
methods
chemotherapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69122960T
Other languages
English (en)
Other versions
DE69122960T2 (de
DE69122960T3 (de
Inventor
David Goeddel
Charles Schmelzer
Grace Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27055814&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69122960(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of DE69122960D1 publication Critical patent/DE69122960D1/de
Publication of DE69122960T2 publication Critical patent/DE69122960T2/de
Application granted granted Critical
Publication of DE69122960T3 publication Critical patent/DE69122960T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5415—Leukaemia inhibitory factor [LIF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69122960T 1990-04-10 1991-04-09 Verfahren und zubereitungen für die behandlung von verletzungen Expired - Lifetime DE69122960T3 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50734190A 1990-04-10 1990-04-10
US60284990A 1990-10-26 1990-10-26
PCT/US1991/002446 WO1991015227A1 (en) 1990-04-10 1991-04-09 Method and compositions for treating injury

Publications (3)

Publication Number Publication Date
DE69122960D1 true DE69122960D1 (de) 1996-12-05
DE69122960T2 DE69122960T2 (de) 1997-04-03
DE69122960T3 DE69122960T3 (de) 2002-05-29

Family

ID=27055814

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69122960T Expired - Lifetime DE69122960T3 (de) 1990-04-10 1991-04-09 Verfahren und zubereitungen für die behandlung von verletzungen

Country Status (11)

Country Link
US (2) US5843422A (de)
EP (2) EP0527852B2 (de)
JP (1) JP3266248B2 (de)
AT (1) ATE144711T1 (de)
CA (1) CA2078544C (de)
DE (1) DE69122960T3 (de)
DK (1) DK0527852T3 (de)
ES (1) ES2095938T3 (de)
GR (1) GR3022097T3 (de)
IL (1) IL97779A (de)
WO (1) WO1991015227A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5370870A (en) * 1989-10-06 1994-12-06 Genentech, Inc. Method for protection against reactive oxygen species
US5200176A (en) * 1989-10-06 1993-04-06 Genentech, Inc. Method for protection of ischemic tissues using tumor nerosis factor
IL97779A (en) * 1990-04-10 2000-01-31 Genentech Inc Compositions for cytoprotection against radiation and chemotherapy injury or risk thereof
DK0554381T3 (da) * 1990-10-25 1996-04-09 Genentech Inc Anvendelse af beskyttende midler mod reaktive oxygenforbindelser
US5460810A (en) * 1992-09-02 1995-10-24 Genetics Institute, Inc. Method for maintaining gut epithelial cells by treatment with a cytokine such as interleukin 11
US7602940B2 (en) 1998-04-16 2009-10-13 Digimarc Corporation Steganographic data hiding using a device clock
FR2786104B1 (fr) * 1998-11-25 2002-12-27 Centre Nat Rech Scient Inhibiteurs de l'activation de nf-kb, et leurs utilisations pharmaceutiques
US8288366B2 (en) 2006-06-20 2012-10-16 Chochinov Ronald H Formulation for hair growth
US8603456B2 (en) * 2009-10-08 2013-12-10 United Technologies Ut Ag Method of treating hair loss with compositions containing interleukin-1
JP5913479B2 (ja) * 2014-08-11 2016-04-27 リゼロン、インク． ヒト成長ホルモンを有効成分として含む発毛の促進用の組成物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4321832A (en) * 1980-03-07 1982-03-30 Rockwell International Corporation High accuracy measuring apparatus
IL75318A (en) * 1984-05-31 1994-08-26 Genentech Inc Recombinant human memotoxin and methods for its recombinant production
GR851626B (de) * 1984-07-05 1985-11-26 Genentech Inc
JPH01501862A (ja) * 1986-03-14 1989-06-29 シェリング・コ−ポレ−ション インタ−フェロン及び放射線療法による癌の治療
DE3613167A1 (de) † 1986-04-18 1987-10-29 Basf Ag Verwendung von tnf zur herstellung von arzneimitteln
IL80005A (en) * 1986-09-10 1992-11-15 Yeda Res & Dev Compositions for modulating the effect of tnf and il-1
US4985241A (en) * 1986-11-21 1991-01-15 Cetus Corporation Therapeutic combination of free-radical scavenger and tumor necrosis factor
PT87133B (pt) * 1987-04-02 1992-07-31 Amrad Corp Ltd Metodo de purificacao do factor inibidor da leucemia (lif) e de composicoes farmaceuticas contendo polipeptidos com actividade do lif
ZA893063B (en) * 1988-04-27 1990-01-31 Immunomedics Inc Improved radiotherapy
WO1990002183A1 (en) * 1988-08-18 1990-03-08 Genetics Institute, Inc. Production of a novel lymphokine exhibiting differentiation inhibitory activity
EP0463004A4 (en) * 1989-03-07 1992-04-01 Amrad Corporation Limited Metabolic effects of leukaemia inhibitory factor on bone
US5370870A (en) * 1989-10-06 1994-12-06 Genentech, Inc. Method for protection against reactive oxygen species
IL97779A (en) * 1990-04-10 2000-01-31 Genentech Inc Compositions for cytoprotection against radiation and chemotherapy injury or risk thereof
US5202119A (en) * 1991-06-28 1993-04-13 Genentech, Inc. Method of stimulating immune response

Also Published As

Publication number Publication date
IL97779A0 (en) 1992-06-21
EP0527852B2 (de) 2001-02-21
WO1991015227A1 (en) 1991-10-17
US5843422A (en) 1998-12-01
DE69122960T2 (de) 1997-04-03
GR3022097T3 (en) 1997-03-31
JPH05506663A (ja) 1993-09-30
EP0731109A1 (de) 1996-09-11
CA2078544A1 (en) 1991-10-11
CA2078544C (en) 2008-02-26
AU7856591A (en) 1991-10-30
EP0527852A1 (de) 1993-02-24
AU638839B2 (en) 1993-07-08
EP0527852B1 (de) 1996-10-30
DK0527852T3 (de) 1997-02-17
ES2095938T3 (es) 1997-03-01
JP3266248B2 (ja) 2002-03-18
IL97779A (en) 2000-01-31
DE69122960T3 (de) 2002-05-29
ATE144711T1 (de) 1996-11-15
US5725851A (en) 1998-03-10

Similar Documents

Publication Publication Date Title
TW229156B (de)
NO304884B1 (no) 9-[(substituerte glycyl)amido]-6-demetyl-6-deoksotetracykliner, og medisinske preparater derav
ATE207355T1 (de) Behandlung von hyperproliferativen gefässerkrankungen
EP0363415A4 (en) Compounds for the treatment of alzheimer's disease
DE3889536D1 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
FI831230L (fi) N-glykosylerade karboxylsyraamidderivat, foerfarande foer deras framstaellning samt deras anvaendnifoer att paoverka kroppens eget foersvar
DE69122960D1 (de) Verfahren und zubereitungen für die behandlung von verletzungen
ATE161013T1 (de) Verfahren zum reinigen von 20 cs)-camptothecin
DE68928756D1 (de) Topische Zubereitungen enthaltend aliphatische Amine zur Behandlung von Hautkrankheiten
ATE124681T1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
DE69300321D1 (de) Behandlung neurodegenerativer Erkrankungen.
ATE69238T1 (de) Monoalkylester-sulfate von glutathion und verfahren zu deren herstellung.
ATE113477T1 (de) Therapeutisch wirksames stoffgemisch aus glutathion- und anthocyan-verbindungen.
IT9086204A0 (it) Metodo per la cura dell'impotenza erettiva maschile
ATE78407T1 (de) Immunotoxine zur behandlung bzw. prophylaxe von autoimmunkrankheiten.
ATE132186T1 (de) Verfahren zur inaktivierung von viren
DK159118C (da) 6alfa-methylprednisolon-derivater og farmaceutiske praeparater der indeholder dem
ATE53384T1 (de) 3-mercapto-2-oxo-1-pyrrolidinessigsaeurederivate verfahren zur herstellung und pharmazeutische zusammensetzungen die sie enthalten.

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings